Content
Regrow hair in as few as 3-6 months
Are you new to our products and want to learn how to apply Hims spray? The right application technique and routine for the Hims hair spray will help you on your way to achieving optimal hair regrowth results.
Our FDA-approved Hims hair spray combines the power of two effective hair loss treatments, minoxidil and finasteride, to help minimize shedding, prevent a receding hairline, and restore healthy hair.
Below, we outline everything you need to know about Hims spray, including how it works, how to apply it, and what its potential side effects are.
Content
Before we outline the best way to apply it, let’s break down how Hims hair spray works to regrow hair.
Hims spray contains two clinically proven active ingredients: minoxidil and finasteride. Both are FDA-approved for hair loss, but they work differently.
Finasteride works to reduce DHT in the scalp. DHT, or dihydrotestosterone, is the male sex hormone responsible for a genetic form of hair loss known as androgenetic alopecia — also referred to as male pattern baldness, or male pattern hair loss.
Minoxidil solution (the generic name for over-the-counter medication Rogaine®) promotes hair regrowth by stimulating dormant hair follicles, encouraging hairs to return to the growth phase of the hair growth cycle, and increasing blood flow to the scalp.
Combined, the two ingredients are a powerful force against hair follicle dysfunction.
Follow these steps when applying Hims spray for optimal hair growth results.
Before you pick up the bottle, part your hair slightly, so the solution can better reach the scalp. Apply the spray by holding the bottle two to three inches away from your head.
When spraying, target the four main zones of hair loss, including:
The crown of the head
The top of your head
Each side of the front of the head (commonly the first place where hair begins to recede)
Even if you’re not currently experiencing hair loss across your scalp, applying the spray to all areas of the head can help prevent hair loss from spreading and creating bald spots.
While it may seem like you need more sprays, the formula is designed to restore hair health without the need to fully soak your head.
Spray one spot at a time, gently massaging the solution into your scalp between sprays.
You may find application a little easier if you tilt your head back slightly while applying and massaging in the hair regrowth treatment. This will help prevent it from running down your forehead and getting into your eyes.
It is important to let the treatment dry completely before you go back to your regular activities — especially if you’re applying it before bed or before putting on a hat.
If you apply the Hims hair spray at night, it’s OK to wash your hair in the morning since the treatment will have had enough time on your scalp to be effective.
Always make sure to wash your hands after applying Hims spray.
And as a safety tip, note that topical finasteride isn’t safe for pregnant people (or people who are trying to become pregnant). If that applies to your partner, avoid sharing a pillow with them, and be cautious about potential exposure.
While Hims spray starts working right away, it can take between three and six months to see visible results.
If your hair looks the same after three months, consider it a success — that means the hair loss hasn’t progressed.
Ultimately, consistency is key. Regularly applying Hims spray and following your healthcare provider’s medical advice will ensure hair growth results are on the way and thinning hair is on the way out.
Here are a few things to keep in mind throughout your treatment with Hims hair growth spray:
Your hair care routine is important. Taking good care of your scalp while you use Hims spray will help encourage healthy hair growth. If you’re experiencing any flaking or itchiness, our Dandruff Detox shampoo can help.
You won’t wash away results. Unless you wash off the solution straight after applying, washing your hair regularly won’t impact the product’s effectiveness. Washing will actually help remove build-up that can prevent the solution from being fully absorbed by the scalp.
You may experience some initial shedding. Minoxidil helps promote new hair growth by making room for healthy new strands. Mature strands may shed during this process. But don’t worry, it’s temporary.
Hims topical solution contains FDA-approved hair loss medications and isn’t likely to produce side effects. But some scalp itching and dryness can happen early on.
It’s important to use the treatment as directed by a medical professional. Spraying more than directed won’t make it more effective and actually can increase your risk of side effects.
If your side effects get worse the longer you use the spray, reach out to your prescribing provider or a dermatologist.
Read our guide to Topical Finasteride & Minoxidil Spray for detailed safety information.
Tackling hair loss doesn’t have to be complicated. Hims minoxidil finasteride spray makes treating hair loss simple and stress-free.
Here’s a recap of how the treatment works:
Apply the spray to all areas of your scalp. Targeting your whole head when you use the product can prevent further hair loss.
Don’t apply more than you need. More isn’t always better, and with this type of hair loss medication, too much of the solution can increase your risk of side effects like itching and irritation.
Take care of your hair. A solid hair care routine will ensure your scalp and hair follicles are primed for new, healthy hair growth. Other products, like hair thickening shampoo and Biotin supplements, can also help on your path to healthier, fuller hair.
Know that it can take time to see results. Hims spray won’t produce instant hair growth, but with a little patience, you’ll see a visible difference.
Ready to get started with our Hims hair loss treatment? Begin by booking an online consultation today.
Hims & Hers has strict sourcing guidelines to ensure our content is accurate and current. We rely on peer-reviewed studies, academic research institutions, and medical associations. We strive to use primary sources and refrain from using tertiary references. See a mistake? Let us know at [email protected]!
Dr. Knox Beasley is a board certified dermatologist specializing in hair loss. He completed his undergraduate studies at the United States Military Academy at West Point, NY, and subsequently attended medical school at Tulane University School of Medicine in New Orleans, LA.
Dr. Beasley first began doing telemedicine during his dermatology residency in 2013 with the military, helping to diagnose dermatologic conditions in soldiers all over the world.
Dr. Beasley is board certified by the American Board of Dermatology, and is a Fellow of the American Academy of Dermatology.
Originally from Nashville, TN, Dr. Beasley currently lives in North Carolina and enjoys spending time outdoors (with sunscreen of course) with his wife and two children in his spare time.
Bachelor of Science, Life Sciences. United States Military Academy.
Doctor of Medicine. Tulane University School of Medicine
Dermatology Residency. San Antonio Uniformed Services Health Education Consortium
Board Certified. American Board of Dermatology
Wilson, L. M., Beasley, K. J., Sorrells, T. C., & Johnson, V. V. (2017). Congenital neurocristic cutaneous hamartoma with poliosis: A case report. Journal of cutaneous pathology, 44(11), 974–977. https://onlinelibrary.wiley.com/doi/10.1111/cup.13027
Banta, J., Beasley, K., Kobayashi, T., & Rohena, L. (2016). Encephalocraniocutaneous lipomatosis (Haberland syndrome): A mild case with bilateral cutaneous and ocular involvement. JAAD case reports, 2(2), 150–152. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867906/
Patterson, A. T., Beasley, K. J., & Kobayashi, T. T. (2016). Fibroelastolytic papulosis: histopathologic confirmation of disease spectrum variants in a single case. Journal of cutaneous pathology, 43(2), 142–147. https://onlinelibrary.wiley.com/doi/10.1111/cup.12569
Beasley, K., Panach, K., & Dominguez, A. R. (2016). Disseminated Candida tropicalis presenting with Ecthyma-Gangrenosum-like Lesions. Dermatology online journal, 22(1), 13030/qt7vg4n68j. https://pubmed.ncbi.nlm.nih.gov/26990472/
Kimes, K., Beasley, K., & Dalton, S. R. (2015). Eruptive milia and comedones during treatment with dovitinib. Dermatology online journal, 21(9), 13030/qt8kw141mb. https://pubmed.ncbi.nlm.nih.gov/26437285/
Miladi, A., Thomas, B. C., Beasley, K., & Meyerle, J. (2015). Angioimmunoblastic t-cell lymphoma presenting as purpura fulminans. Cutis, 95(2), 113–115. https://pubmed.ncbi.nlm.nih.gov/25750965/
Beasley K, Dai JM, Brown P, Lenz B, Hivnor CM. (2013). Ablative Fractional Versus Nonablative Fractional Lasers – Where Are We and How Do We Compare Differing Products?. Curr Dermatol Rep, 2, 135–143. https://idp.springer.com/authorize?response_type=cookie&client_id=springerlink&redirect_uri=https%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs13671-013-0043-0
Siami P, Beasley K, Woolen S, Zahn J. (2012). A retrospective study evaluating the efficacy and tolerability of intra-abdominal once-yearly histrelin acetate subcutaneous implant in patients with advanced prostate cancer. UroToday Int J, June 5(3), art 26. https://www.urotoday.com/volume-5-2012/vol-5-issue-3/51132-a-retrospective-study-evaluating-the-efficacy-and-tolerability-of-intra-abdominal-once-yearly-histrelin-acetate-subcutaneous-implants-in-patients-with-advanced-prostate-cancer.html
Siami P, Beasley K. (2012). Dutasteride with As-Needed Tamsulosin in Men at Risk of Benign Prostate Hypertrophy Progression. UroToday Int J, Feb 5(1), art 93. https://www.urotoday.com/volume-5-2012/vol-5-issue-1/48691-dutasteride-with-as-needed-tamsulosin-in-men-at-risk-of-benign-prostatic-hypertrophy-progression.html